Remembering the patient in the Cancer Drugs Fund debate
September 5, 2014Medical Communications, Sales and Marketing Beating Bowel Cancer, Cancer Drugs Fund, Kadclya, Roche
Today Simon is a bowel cancer patient who is able to enjoy his weekly round of golf.After receiving the dreadful …
Edelman buys Elan to ‘challenge’ the French PR industry
September 5, 2014Medical Communications, Sales and Marketing Edelman, Elan, publicis
Edelman has swooped in on fellow PR firm Elan to create a ‘new player’ in the communications industry in France. …
NHS spends over £1 million on Apple products
September 5, 2014Medical Communications, Sales and Marketing Apple, NHS England, ipad, iphone
NHS England has spent more than £1.2 million on Apple’s tablets and smartphones since it was set up two years’ …
Merck surprise winner in PD-1 race
September 5, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, Merck, melanoma, pd-1
Merck has become the first company to bring a new class of cancer drug to the US market after the …
J&J fast-track Ebola vaccine for early 2015 trials
September 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, Mapp, zmapp
Johnson & Johnson has announced it is to fast-track the development of a new vaccine programme to fight the deadly …
Teva launches new MS eHealth site
September 4, 2014Medical Communications, Sales and Marketing Teva, digital, ms ireland, multiple sclerosis, pow health
Teva and MS Ireland have helped launch a new website called Pow Health to give multiple sclerosis patients a “one-stop …
AbbVie and Infinity sign cancer deal
September 4, 2014Research and Development, Sales and Marketing AbbVie, IPI-145, blood cancer, duvelisib, infinity
AbbVie has partnered with US company Infinity Pharmaceuticals to develop and commercialise the latter firm’s blood cancer treatment duvelisib (IPI-145). …
New chief executive for Healthcare Communications Association
September 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anneliese Cameron, HCA, Healthcare Communications Association, julia cook
The Healthcare Communications Association (HCA) has a new chief executive in Anneliese Cameron who replaces Julia Cook next year in …
Google partners with AbbVie on ageing
September 4, 2014Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google
Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …
ICON appoints vice president from Allergan
September 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, ira spector
Healthcare outsourced development firm ICON has hired Dr Ira Spector to be the executive vice president of its analytics and …
NICE backs world’s most expensive medicine
September 4, 2014Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris
In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …
Mixed results for AZ’s troubled Brilinta
September 3, 2014Sales and Marketing AstraZeneca, Brilinta, EMA, PCI, atlantic, heart, stent
The latest trial for AstraZeneca’s heart drug Brilinta (ticagrelor) has failed to meet expected results but suggests more flexible applications …
Should patients be able to email their general practitioner?
September 3, 2014Medical Communications, Sales and Marketing BMJ, GPs, clinicians, econsultations, email
Email consultations with your doctor make better use of their time and are more convenient, or threaten safety and create …
BioData appoints new chief executive
September 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Louis Culot, biodata, culot
Digital science portfolio firm BioData that produces web-based research and lab management service Labguru, has appointed Louis Culot as its …
NICE: Cancer Drugs Fund must use our processes
September 3, 2014Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche
NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …
Novo Nordisk scraps inflammatory disorders business
September 2, 2014Research and Development, Sales and Marketing Danish, IL20, Novo Nordisk, diabetes, inflammatory, thomsen
A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …
Fishawack opens US office in San Francisco
September 2, 2014Medical Communications US, comms, communications, fishawack, san francisco
Medical communications firm Fishawack has opened a new office in San Francisco in the US. Under its flagship Fishawack Communications brand …
EMA hires head of comms and HR
September 2, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Manuel Ortigão, Marie-Agnes Heine
The European Medicines Agency has confirmed two new appointments to join its management team. Marie-Agnes Heine (pictured) has joined to …
Children’s cancer death rates drop
September 2, 2014Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, Cancer Research UK, child, death rates
The rate of children dying from cancer has dropped by 22% in the last decade, according to new data published …
Ben Venue problems continue for Boehringer
September 2, 2014Manufacturing and Production, Sales and Marketing Ben Venue, Boehringer, fad, german, manufacturing, recall
Boehringer Ingelheim’s tribulations at its US production site Ben Venue Laboratories are refusing to leave as more of its products …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
